Reuters -- Questcor Pharmaceuticals Inc said U.S. health regulators have accepted its filing for marketing approval for its drug Acthar’s additional indication to treat infantile spasms and set an action date of June 11, 2010.
Reuters -- Questcor Pharmaceuticals Inc said U.S. health regulators have accepted its filing for marketing approval for its drug Acthar’s additional indication to treat infantile spasms and set an action date of June 11, 2010.
